Ellen Cunningham, MD
Dermatology · Mishawaka, INNPI 1205902186
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $638 of the $723 with a category attached, or 88.2%. 14 manufacturers reported payments, led by Novartis at 28.1% of the total. That places this record below the midpoint for dermatology clinicians in IN, where the typical reported total is $3,818.
Across 33 payments — averaging $21.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$203
- AbbVie$98
- Johnson & Johnson$85
- Dermavant Sciences, Inc.$63
- Atricure, Inc.$50
- Sun Pharmaceutical Industries Inc.$40
- plus $182 from 8 others
What the payments were for
- Food & beverage$63888%
- Education$8512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 11 | $203 |
| AbbVie | 5 | $98 |
| Johnson & Johnson | 1 | $85 |
| Dermavant Sciences, Inc. | 4 | $63 |
| Atricure, Inc. | 1 | $50 |
| Sun Pharmaceutical Industries Inc. | 2 | $40 |
| Genentech USA, Inc. | 2 | $32 |
| Almirall LLC | 1 | $31 |
| Fresenius Kabi USA, LLC | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Amgen | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Mission Pharmacal Company | 1 | $12 |
How this compares
$723 in reported general payments places this provider in the 25th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 40 | $3,040 |
| Clobetasol Propionate | 63 | $2,867 |
| Metronidazole | 18 | $1,636 |
| Tretinoin | 19 | $1,294 |
| Doxycycline Hyclate | 37 | $1,010 |
| Minocycline Hcl | 54 | $961 |
| Clindamycin Phosphate | 24 | $900 |
| Fluocinonide | 18 | $567 |
| Triamcinolone Acetonide | 55 | $526 |
| Clotrimazole | 17 | $474 |
| ValacyclovirValacyclovir Hcl | 20 | $370 |
| Mupirocin | 36 | $341 |
| Ketoconazole | 24 | $295 |
| Cephalexin | 21 | $164 |
| Spironolactone | 20 | $152 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mishawaka
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
- Priya YoungIndianapolis$492K
- Jeffrey SassmannshausenFort Wayne$489K
- Nikolajs PerdueIndianapolis$302K
- Michael SheehanColumbus$297K
- Alfred KnableNew Albany$203K
- Megan LandisCorydon$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.